Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: U.S. Food and Drug Administration Office of Special Medical Programs | Statement: [White Oak, Maryland, isNearFederalFacility, U.S. Food and Drug Administration Office of Special Medical Programs]

Target entity: U.S. Food and Drug Administration Office of Special Medical Programs
Context triple: [White Oak, Maryland, isNearFederalFacility, U.S. Food and Drug Administration Office of Special Medical Programs]

• A. Office of Orphan Products Development
  The Office of Orphan Products Development is a U.S. Food and Drug Administration office that promotes the development of drugs and other medical products for rare diseases and conditions.
• B. Office of Regulatory Affairs
  The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
• C. FDA CFSAN
  FDA CFSAN is the U.S. Food and Drug Administration’s center responsible for regulating the safety, labeling, and nutritional quality of foods, dietary supplements, and cosmetics.
• D. Center for Drug Evaluation and Research
  The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
• E. Center for Biologics Evaluation and Research
  The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: U.S. Food and Drug Administration Office of Special Medical Programs
Triple: [White Oak, Maryland, isNearFederalFacility, U.S. Food and Drug Administration Office of Special Medical Programs]

The U.S. Food and Drug Administration Office of Special Medical Programs is an FDA office that oversees cross-cutting medical policy initiatives and specialized regulatory programs to ensure the safety and effectiveness of medical products.

Target entity: U.S. Food and Drug Administration Office of Special Medical Programs
Target entity description: The U.S. Food and Drug Administration Office of Special Medical Programs is an FDA office that oversees cross-cutting medical policy initiatives and specialized regulatory programs to ensure the safety and effectiveness of medical products.

• A. Office of Orphan Products Development
  The Office of Orphan Products Development is a U.S. Food and Drug Administration office that promotes the development of drugs and other medical products for rare diseases and conditions.
• B. Office of Regulatory Affairs
  The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
• C. FDA CFSAN
  FDA CFSAN is the U.S. Food and Drug Administration’s center responsible for regulating the safety, labeling, and nutritional quality of foods, dietary supplements, and cosmetics.
• D. Center for Drug Evaluation and Research
  The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
• E. Center for Biologics Evaluation and Research
  The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
• F. None of above. chosen